ArticleCommunications biology2025

Development of an ultrahigh affinity, trimeric ACE2 biologic as a universal SARS-CoV-2 antagonist.

Juliet Gonzales et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.